Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myelogenous leukemia with a hypooctoploid cell population

T Shichishima1, Y Hamazaki, R Abe

  • 1Department of Internal Medicine I, Fukushima Medical College, Japan.

Cancer Genetics and Cytogenetics
|April 1, 1997
PubMed
Summary

Interferon-alpha treatment successfully reverted accelerated phase chronic myelogenous leukemia to the chronic phase. This therapy eliminated both hypotetraploid and hypooctoploid Philadelphia chromosome-positive cell clones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staged spinal cord decompression through posterior approach for thoracic myelopathy caused by ossification of posterior longitudinal ligament.

Spine·2001
Same author

Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages.

The Journal of experimental medicine·2001
Same author

Occurrence of coring in insulin vials and possibility of rubber piece contamination by self-injection.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2001
Same author

Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery.

Cancer·2001
Same author

High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis.

The Journal of investigative dermatology·2001
Same author

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Journal of immunology (Baltimore, Md. : 1950)·2001

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome.
  • Transformation to accelerated phase indicates disease progression and poorer prognosis.
  • Interferon-alpha has been used in CML treatment, but its efficacy in advanced phases with complex cytogenetics is of interest.

Observation:

  • A patient presented with chronic myelogenous leukemia in the accelerated phase.
  • Peripheral blood and bone marrow showed increased myeloblasts and promyelocytes, with elevated platelet counts and frequent megakaryocytes.
  • Cytogenetic analysis revealed hypotetraploid and hypooctoploid cell populations, each with multiple Philadelphia chromosomes.

Findings:

  • Interferon-alpha therapy led to the disappearance of the hypooctoploid clone.

Related Experiment Videos

  • Subsequently, the hypotetraploid clone also disappeared, indicating a molecular and cytogenetic remission.
  • The patient transformed from the accelerated phase back to the chronic phase.

    • Implications:

    • This case demonstrates the potential of interferon-alpha to induce remission in advanced CML with complex cytogenetic abnormalities.
    • Targeting specific Philadelphia chromosome clones may be a viable therapeutic strategy.
    • Further research into interferon-alpha's role in managing CML transformation is warranted.